{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:43:59Z","timestamp":1777927439846,"version":"3.51.4"},"reference-count":158,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31700546"],"award-info":[{"award-number":["31700546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.bbagen.2022.130113","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T03:34:31Z","timestamp":1645500871000},"page":"130113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mechanistic insights expatiating the biological role and regulatory implications of estrogen and HER2 in breast cancer metastasis"],"prefix":"10.1016","volume":"1866","author":[{"given":"Mohsin Ahmad","family":"Ghauri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uzma","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveel","family":"Atif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafiz M.N.","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Bilal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2022.130113_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbagen.2022.130113_bb0010","first-page":"e1027","article-title":"Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study, lancet","volume":"8","author":"Heer","year":"2020","journal-title":"Glob. Health"},{"key":"10.1016\/j.bbagen.2022.130113_bb0015","first-page":"46","volume":"34","author":"The Evolution of Breast Cancer Care","year":"2020","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.bbagen.2022.130113_bb0020","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10549-020-05735-x","article-title":"The bottom line for lesion localization in breast cancer","volume":"182","author":"Ahmed","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbagen.2022.130113_bb0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13304-017-0424-1","article-title":"Breast cancer in young women: an overview","volume":"69","author":"Anastasiadi","year":"2017","journal-title":"Updat. Surg."},{"key":"10.1016\/j.bbagen.2022.130113_bb0030","first-page":"246","article-title":"Epigenetics in breast cancer","volume":"35","author":"Atalay","year":"2013","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph14050523","article-title":"Geographical variation in breast cancer outcomes","volume":"14","author":"Baade","year":"2017","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.bbagen.2022.130113_bb0040","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.2174\/1381612819666131125145517","article-title":"Breast cancer biomarkers: risk assessment, diagnosis, prognosis, prediction of treatment efficacy and toxicity, and recurrence","volume":"20","author":"Braden","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbagen.2022.130113_bb0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/bcr3045","article-title":"Breast cancer: current state and future promise","volume":"13","author":"Chodosh","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbagen.2022.130113_bb0050","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3322\/caac.20134","article-title":"Breast cancer statistics, 2011, CA","volume":"61","author":"DeSantis","year":"2011","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.bbagen.2022.130113_bb0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.semerg.2014.03.014","article-title":"Actualizaci\u00f3n del c\u00e1ncer de mama en atenci\u00f3n primaria (V\/V)","volume":"41","author":"D\u00edaz Garc\u00eda","year":"2015","journal-title":"Semergen"},{"key":"10.1016\/j.bbagen.2022.130113_bb0060","first-page":"1","article-title":"Management of breast cancer 50 years ago","volume":"81","author":"Ellis","year":"2020","journal-title":"Br. J. Hosp. Med. (Lond.)"},{"key":"10.1016\/j.bbagen.2022.130113_bb0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-030-20301-6_4","article-title":"Breast Cancer: current perspectives on the disease status","volume":"1152","author":"Fahad Ullah","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.critrevonc.2016.02.017","article-title":"Male breast cancer is not congruent with the female disease","volume":"101","author":"Fentiman","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-16366-6_1","article-title":"Breast cancer survivorship: where are we today?","volume":"862","author":"Ganz","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22339","article-title":"An efficient or methodical review of immunotherapy against breast cancer","volume":"33","author":"Guanghui","year":"2019","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11845-014-1142-z","article-title":"Breast cancer: from Halsted to Harney","volume":"184","author":"Kell","year":"2015","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.bbagen.2022.130113_bb0090","doi-asserted-by":"crossref","first-page":"549","DOI":"10.26444\/aaem\/75943","article-title":"Primary and secondary prevention of breast cancer","volume":"24","author":"Kolak","year":"2017","journal-title":"Ann. Agric. Environ. Med."},{"key":"10.1016\/j.bbagen.2022.130113_bb0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s15006-016-7660-z","article-title":"Hohe Heilungschancen bei Brustkrebs","volume":"158","author":"Krockenberger","year":"2016","journal-title":"MMW-Fortschritte Med."},{"key":"10.1016\/j.bbagen.2022.130113_bb0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/15748928113086660046","article-title":"Breast Cancer: current developments in molecular approaches to diagnosis and treatment","volume":"9","author":"la Mare","year":"2014","journal-title":"Recent Pat. Anticancer. Drug Discov."},{"key":"10.1016\/j.bbagen.2022.130113_bb0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-016-4059-6","article-title":"Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer","volume":"161","author":"Li","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbagen.2022.130113_bb0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/09540261.2013.852971","article-title":"A review of clinical aspects of breast cancer","volume":"26","author":"Libson","year":"2014","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.bbagen.2022.130113_bb0115","first-page":"1339","article-title":"Treatment of breast cancer","volume":"81","author":"Maughan","year":"2010","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.bbagen.2022.130113_bb0120","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.suc.2018.03.009","article-title":"Inflammatory breast Cancer: what to know about this unique, aggressive breast Cancer","volume":"98","author":"Menta","year":"2018","journal-title":"Surg. Clin. North Am."},{"key":"10.1016\/j.bbagen.2022.130113_bb0125","first-page":"401M","article-title":"Precision medicine in breast cancer","volume":"88","author":"Odle","year":"2017","journal-title":"Radiol. Technol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.seminoncol.2017.02.004","article-title":"Screening for breast cancer","volume":"44","author":"Peairs","year":"2017","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0135","first-page":"15","article-title":"Breast cancer","volume":"30","author":"Pearce","year":"2016","journal-title":"Nurs. Stand."},{"key":"10.1016\/j.bbagen.2022.130113_bb0140","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1188\/14.ONF.639-646","article-title":"Deconstructing breast cancer heterogeneity: clinical implications for women with basal-like tumors","volume":"41","author":"Rattani","year":"2014","journal-title":"Oncol. Nurs. Forum"},{"key":"10.1016\/j.bbagen.2022.130113_bb0145","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/PL00000864","article-title":"Cell-matrix contact structures","volume":"58","author":"Adams","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbagen.2022.130113_bb0150","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0959-8049(99)00279-8","article-title":"In vitro and in vivo effects of a cyclic peptide with affinity for the \u03b1v\u03b23 integrin in human melanoma cells","volume":"36","author":"Allman","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbagen.2022.130113_bb0155","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jnci\/93.18.1375","article-title":"Epidermal growth factor receptor signalling and the invasive phenotype of ovarian carcinoma cells","volume":"93","author":"Alper","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbagen.2022.130113_bb0160","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1083\/jcb.200107107","article-title":"Marching at the front and dragging behind: differential \u03b1V\u03b23-integrin turnover regulates focal adhesion behavior","volume":"155","author":"Ballestrem","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0165","first-page":"11","article-title":"Variability of cell size in primary and metastatic human breast carcinoma","volume":"6","author":"Bell","year":"1986","journal-title":"Invasion Metastasis"},{"key":"10.1016\/j.bbagen.2022.130113_bb0170","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/35010008","article-title":"Direct observation of dendritic actin filament networks nucleated by Arp2\/3 complex and WASP\/scar proteins","volume":"404","author":"Blancholn","year":"2000","journal-title":"Nature."},{"key":"10.1016\/j.bbagen.2022.130113_bb0175","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1074-7613(02)00281-9","article-title":"\u03b21 integrin is not essential for hematopoiesis but is necessary for the T cell-dependent IgM antibody response","volume":"16","author":"Brakebusch","year":"2002","journal-title":"Immunity."},{"key":"10.1016\/j.bbagen.2022.130113_bb0180","first-page":"4556","article-title":"Isolation of prostate-derived single cells and cell clusters from human peripheral blood","volume":"56","author":"Brandt","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2022.130113_bb0185","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0092-8674(00)81380-X","article-title":"Getting membrane flow and the cytoskeleton to cooperate in moving cells","volume":"87","author":"Bretscher","year":"1996","journal-title":"Cell."},{"key":"10.1016\/j.bbagen.2022.130113_bb0190","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI119298","article-title":"Insulin-like growth factor receptor cooperates with integrin \u03b1v\u03b25 to promote tumor cell dissemination in vivo","volume":"99","author":"Brooks","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2022.130113_bb0195","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0092-8674(00)80931-9","article-title":"Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity","volume":"92","author":"Brooks","year":"1998","journal-title":"Cell."},{"key":"10.1016\/j.bbagen.2022.130113_bb0200","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.cellbio.12.1.463","article-title":"Focal adhesions, contractility, and signaling","volume":"12","author":"Burridge","year":"1996","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0205","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1242\/jcs.108.5.2053","article-title":"Role of E-cadherin in the response of tumor cell aggregates to lymphatic, venous and arterial flow: measurement of cell-cell adhesion strength","volume":"108","author":"Byers","year":"1995","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbagen.2022.130113_bb0210","doi-asserted-by":"crossref","first-page":"22607","DOI":"10.1074\/jbc.R900037199","article-title":"Integrins and actin filaments: reciprocal regulation of cell adhesion and signaling","volume":"275","author":"Calderwood","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2022.130113_bb0215","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1083\/jcb.147.3.619","article-title":"Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and Talin","volume":"147","author":"Carragher","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0220","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbagen.2022.130113_bb0225","first-page":"4811","article-title":"A function for the integrin \u03b16\u03b24 in the invasive properties of colorectal carcinoma cells","volume":"56","author":"Chao","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2022.130113_bb0230","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1083\/jcb.200110161","article-title":"A fluorescent resonant energy transfer-based biosensor reveals transient and regional myosin light chain kinase activation in lamella and cleavage furrows","volume":"156","author":"Chew","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0235","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/35082119","article-title":"Erratum: genomic analysis of metastasis reveals an essential role for RhoC (nature (2000) 406 (532-535))","volume":"411","author":"Clark","year":"2001","journal-title":"Nature."},{"key":"10.1016\/j.bbagen.2022.130113_bb0240","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1182\/blood-2002-05-1593","article-title":"Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix","volume":"101","author":"Collen","year":"2003","journal-title":"Blood."},{"key":"10.1016\/j.bbagen.2022.130113_bb0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00047603","article-title":"Chemotaxis of metastatic tumor cells: clues to mechanisms from the Dictyostelium paradigm","volume":"11","author":"Condeelis","year":"1992","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbagen.2022.130113_bb0250","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1126\/science.1067100","article-title":"Matrix metalloproteinase inhibitors and cancer: trials and tribulations","volume":"295","author":"Coussens","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2022.130113_bb0255","first-page":"173","article-title":"Organization and polarity of actin filament networks in cells: implications for the mechanism of myosin-based cell motility","volume":"65","author":"Cramer","year":"1999","journal-title":"Biochem. Soc. Symp."},{"key":"10.1016\/j.bbagen.2022.130113_bb0260","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00690293","article-title":"The \u03b16\u03b21 and \u03b16\u03b24 integrins in human prostate cancer progression","volume":"14","author":"Cress","year":"1995","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbagen.2022.130113_bb0265","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1126\/science.1064829","article-title":"Taking cell-matrix adhesions to the third dimension","volume":"294","author":"Cukierman","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2022.130113_bb0270","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ijc.2910540225","article-title":"Regulation of integrin-mediated adhesion to laminin and collagen in human melanocytes and in non-metastatic and highly metastatic human melanoma cells","volume":"54","author":"Danen","year":"1993","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbagen.2022.130113_bb0275","first-page":"316","article-title":"Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene","volume":"63","author":"Dartsch","year":"1994","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0280","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-3-030-16391-4_2","article-title":"Update on precision medicine in breast Cancer","volume":"178","author":"Sachdev","year":"2019","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.bbagen.2022.130113_bb0285","first-page":"232","article-title":"Systemic treatment of early breast cancer - current state of knowledge after the conference St Gallen 2017","volume":"43","author":"Sarosiek","year":"2017","journal-title":"Pol. Merkur. Lekarski"},{"key":"10.1016\/j.bbagen.2022.130113_bb0290","first-page":"392","article-title":"Physical activity influences the immune system of breast cancer patients","volume":"13","author":"Schmidt","year":"2017","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.bbagen.2022.130113_bb0295","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/jjco\/hyaa055","article-title":"Omitting surgery for early breast cancer showing clinical complete response to primary systemic therapy","volume":"50","author":"Shigematsu","year":"2020","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0300","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.6004\/jnccn.2013.0128","article-title":"Breast cancer in adolescents and young adults: a review with a focus on biology","volume":"11","author":"Tichy","year":"2013","journal-title":"JNCCN J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.bbagen.2022.130113_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.08.004","article-title":"Therapeutic landscape of metaplastic breast cancer","volume":"79","author":"Tray","year":"2019","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbagen.2022.130113_bb0310","first-page":"280","article-title":"Follow-up of breast cancer patients by general practioner","volume":"39","author":"Veys","year":"2018","journal-title":"Rev. Med. Brux."},{"key":"10.1016\/j.bbagen.2022.130113_bb0315","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1038\/527S101a","article-title":"Breast cancer","volume":"527","author":"Woolston","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2022.130113_bb0320","first-page":"55","article-title":"Breast cancer: basics, screening, diagnostics and treatment","volume":"40","author":"W\u00f6rmann","year":"2017","journal-title":"Med. Monatsschr. Pharm."},{"key":"10.1016\/j.bbagen.2022.130113_bb0325","first-page":"88","article-title":"Breast reconstruction after mastectomy in breast cancer patients: specialization and standardization","volume":"57","author":"Ye","year":"2019","journal-title":"Zhonghua Wai Ke Za Zhi."},{"key":"10.1016\/j.bbagen.2022.130113_bb0330","article-title":"Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer","volume":"40","author":"Zhang","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbagen.2022.130113_bb0335","first-page":"1","article-title":"Ribosomes as a nexus between translation and cancer progression: focus on ribosomal receptor for activated C kinase 1 (RACK1) in breast cancer","volume":"179","author":"Buoso","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0340","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1111\/bph.15205","article-title":"The 5,6-epoxycholesterol metabolic pathway in breast cancer: emergence of new pharmacological targets","volume":"178","author":"de Medina","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0345","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1111\/bph.13211","article-title":"Therapeutic targets of triple-negative breast cancer: a review","volume":"172","author":"Jamdade","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0350","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41586-020-2969-2","article-title":"A metastasis map of human cancer cell lines","volume":"588","author":"Jin","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.bbagen.2022.130113_bb0355","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41467-020-20733-9","article-title":"Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung","volume":"12","author":"Tyagi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbagen.2022.130113_bb0360","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.28086","article-title":"Development and validation of a preoperative magnetic resonance imaging Radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast Cancer","volume":"3","author":"Yu","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bbagen.2022.130113_bb0365","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00262-020-02736-z","article-title":"Pembrolizumab and atezolizumab in triple-negative breast cancer","volume":"70","author":"Kwapisz","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbagen.2022.130113_bb0370","doi-asserted-by":"crossref","first-page":"7196","DOI":"10.1038\/s41388-020-01494-7","article-title":"PRRG4 promotes breast cancer metastasis through the recruitment of NEDD4 and downregulation of Robo1","volume":"39","author":"Zhang","year":"2020","journal-title":"Oncogene."},{"key":"10.1016\/j.bbagen.2022.130113_bb0375","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.breast.2020.10.012","article-title":"Occult breast cancer: where are we at?","volume":"54","author":"Ofri","year":"2020","journal-title":"Breast."},{"key":"10.1016\/j.bbagen.2022.130113_bb0380","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41388-020-01588-2","article-title":"Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance","volume":"40","author":"Yousefi","year":"2021","journal-title":"Oncogene."},{"key":"10.1016\/j.bbagen.2022.130113_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21218415","article-title":"How to predict metastasis in luminal breast cancer? Current solutions and future prospects","volume":"21","author":"Tabor","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbagen.2022.130113_bb0390","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41388-020-01539-x","article-title":"VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk","volume":"40","author":"Kong","year":"2021","journal-title":"Oncogene."},{"key":"10.1016\/j.bbagen.2022.130113_bb0395","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000022527","article-title":"Widespread metastasis to the stomach 10 years after primary breast cancer: a case report and review of the literature","volume":"99","author":"Fu","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbagen.2022.130113_bb0400","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I\u2013III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0405","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41388-020-01603-6","article-title":"Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions","volume":"40","author":"Pantano","year":"2021","journal-title":"Oncogene."},{"key":"10.1016\/j.bbagen.2022.130113_bb0410","doi-asserted-by":"crossref","first-page":"678","DOI":"10.5858\/arpa.2019-0559-RA","article-title":"Liquid biopsy in breast cancer: a focused review","volume":"145","author":"Tay","year":"2021","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.bbagen.2022.130113_bb0415","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2020.10.037","article-title":"Macrophages-stimulated PRMT1-mediated EZH2 methylation promotes breast cancer metastasis","volume":"533","author":"Li","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2022.130113_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21249457","article-title":"Current status of circulating tumor cells, circulating tumor DNA, and exosomes in breast cancer liquid biopsies","volume":"21","author":"Tellez-Gabriel","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbagen.2022.130113_bb0425","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41388-020-01499-2","article-title":"OSR1 phosphorylates the Smad2\/3 linker region and induces TGF-\u03b21 autocrine to promote EMT and metastasis in breast cancer","volume":"40","author":"Li","year":"2021","journal-title":"Oncogene."},{"key":"10.1016\/j.bbagen.2022.130113_bb0430","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jso.26248","article-title":"Metaplastic breast cancer: prognostic and therapeutic considerations","volume":"123","author":"Corso","year":"2021","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0435","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/acs.jmedchem.0c01477","article-title":"Sialyltransferase inhibitors suppress breast cancer metastasis","volume":"64","author":"Fu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2022.130113_bb0440","doi-asserted-by":"crossref","first-page":"19626","DOI":"10.1038\/s41598-020-76577-2","article-title":"The diagnostic value of DNA repair gene in breast cancer metastasis","volume":"10","author":"Yang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagen.2022.130113_bb0445","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-981-32-9620-6_9","article-title":"Breast Cancer metastasis","volume":"1187","author":"Kim","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0450","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12282-020-01120-0","article-title":"Axillary surgery for breast cancer: past, present, and future","volume":"28","author":"Noguchi","year":"2021","journal-title":"Breast Cancer"},{"key":"10.1016\/j.bbagen.2022.130113_bb0455","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.bbrc.2020.07.059","article-title":"Pivalopril improves anti-cancer efficiency of cDDP in breast cancer through inhibiting proliferation, angiogenesis and metastasis","volume":"533","author":"Fei","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2022.130113_bb0460","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neo.2020.12.011","article-title":"Opioids drive breast cancer metastasis through the \u03b4-opioid receptor and oncogenic STAT3","volume":"23","author":"Tripolt","year":"2021","journal-title":"Neoplasia."},{"key":"10.1016\/j.bbagen.2022.130113_bb0465","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12966","article-title":"The long non-coding RNA landscape in triple-negative breast cancer","volume":"54","author":"Zhang","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bbagen.2022.130113_bb0470","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1111\/tbj.14090","article-title":"Schwannoma associated with breast cancer mimicking axillary metastasis","volume":"26","author":"Vieira","year":"2020","journal-title":"Breast J."},{"key":"10.1016\/j.bbagen.2022.130113_bb0475","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ajpath.2020.11.013","article-title":"Insulin-induced gene 2 expression is associated with breast cancer metastasis","volume":"191","author":"Lu","year":"2021","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0480","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024164","article-title":"Clinicopathologic features of single bone metastasis in breast cancer","volume":"100","author":"Karatas","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbagen.2022.130113_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110956","article-title":"Transcriptional co-activators YAP\/TAZ: potential therapeutic targets for metastatic breast cancer","volume":"133","author":"Zhao","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.bbagen.2022.130113_bb0490","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bbagen.2022.130113_bb0495","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bbagen.2022.130113_bb0500","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jcp.21940","article-title":"Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis","volume":"222","author":"Kuhn","year":"2010","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bbagen.2022.130113_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.2727","article-title":"Current and emerging concepts in tumour metastasis","volume":"222","author":"Coghlin","year":"2010","journal-title":"J. Pathol."},{"issue":"11","key":"10.1016\/j.bbagen.2022.130113_bb0510","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/0008-5472.CAN-07-0912","article-title":"Tumor-associated macrophages press the angiogenic switch in breast cancer","volume":"67","author":"Lin","year":"2007","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbagen.2022.130113_bb0515","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ccr.2009.03.016","article-title":"Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion","volume":"15","author":"Wu","year":"2009","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.bbagen.2022.130113_bb0520","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1158\/1078-0432.CCR-08-2179","article-title":"Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination","volume":"15","author":"Robinson","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbagen.2022.130113_bb0525","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4161\/cbt.188","article-title":"Distant metastasis in breast cancer: molecular mechanisms and therapeutic targets","volume":"2","author":"Parker","year":"2003","journal-title":"Cancer Biol. Ther."},{"issue":"4","key":"10.1016\/j.bbagen.2022.130113_bb0530","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1535-6108(02)00153-8","article-title":"MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis","volume":"2","author":"Hiratsuka","year":"2002","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbagen.2022.130113_bb0535","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1172\/JCI22320","article-title":"Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors","volume":"115","author":"Minn","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"7050","key":"10.1016\/j.bbagen.2022.130113_bb0540","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature03799","article-title":"Genes that mediate breast cancer metastasis to lung","volume":"436","author":"Minn","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbagen.2022.130113_bb0545","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.critrevonc.2006.02.007","article-title":"Angiogenesis and cancer: a cross-talk between basic science and clinical trials (the \u201cdo ut des\u201d paradigm)","volume":"59","author":"de Castro Junior","year":"2006","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.bbagen.2022.130113_bb0550","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bbagen.2022.130113_bb0555","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrc1477","article-title":"Friends or foes - bipolar effects of the tumour stroma in cancer","volume":"4","author":"Mueller","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbagen.2022.130113_bb0560","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/281261","article-title":"Targeting the tumor microenvironment: focus on angiogenesis","volume":"2012","author":"Fan","year":"2012","journal-title":"J. Oncol."},{"issue":"5706","key":"10.1016\/j.bbagen.2022.130113_bb0565","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science (New York, N.Y.)"},{"issue":"2","key":"10.1016\/j.bbagen.2022.130113_bb0570","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mam.2011.04.001","article-title":"Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies","volume":"32","author":"Leite de Oliveira","year":"2011","journal-title":"Mol. Asp. Med."},{"issue":"6","key":"10.1016\/j.bbagen.2022.130113_bb0575","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm0603-677","article-title":"Regulation of angiogenesis by hypoxia: role of the HIF system","volume":"9","author":"Pugh","year":"2003","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.bbagen.2022.130113_bb0580","first-page":"1011","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis, journal of clinical oncology\u202f: official journal of the American society of","volume":"23","author":"Hicklin","year":"2005","journal-title":"Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbagen.2022.130113_bb0585","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/07357900701662509","article-title":"Tumoral angiogenesis: review of the literature","volume":"26","author":"Khosravi Shahi","year":"2008","journal-title":"Cancer Investig."},{"issue":"21","key":"10.1016\/j.bbagen.2022.130113_bb0590","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1200\/JCO.2002.10.088","article-title":"Vascular permeability factor\/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy","volume":"20","author":"Dvorak","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bbagen.2022.130113_bb0595","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00428-009-0784-0","article-title":"Cancer invasion and metastasis: interacting ecosystems","volume":"454","author":"Mareel","year":"2009","journal-title":"Virchows Arch."},{"issue":"4","key":"10.1016\/j.bbagen.2022.130113_bb0600","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2165\/00003495-200059040-00003","article-title":"Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents","volume":"59","author":"Noonberg","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.bbagen.2022.130113_bb0605","first-page":"S33","article-title":"Open-label, phase II, multicenter trial of ZD1839 (\u2019Iressa\u2019) in patients with advanced breast cancer","volume":"76","author":"Albain","year":"2002","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.bbagen.2022.130113_bb0610","first-page":"85","article-title":"The effects of the novel, reversible epidermal growth factor receptor\/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo","volume":"1","author":"Rusnak","year":"2001","journal-title":"Mol. Cancer Ther."},{"issue":"41","key":"10.1016\/j.bbagen.2022.130113_bb0615","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1038\/sj.onc.1205794","article-title":"Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR\/erbB2 and downstream Erk1\/2 and AKT pathways","volume":"21","author":"Xia","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bbagen.2022.130113_bb0620","doi-asserted-by":"crossref","first-page":"22607","DOI":"10.1074\/jbc.R900037199","article-title":"Integrins and actin filaments: reciprocal regulation of cell adhesion and signaling","volume":"275","author":"Calderwood","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2022.130113_bb0625","first-page":"4484","article-title":"Activation of small GTPase rho is required for autocrine motility factor signaling","volume":"62","author":"Tsutsumi","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2022.130113_bb0630","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1242\/jcs.1.4.407","article-title":"Movements of epithelial cell sheets in vitro","volume":"1","author":"Vaughan","year":"1966","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbagen.2022.130113_bb0635","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1083\/jcb.131.4.989","article-title":"Myosin II filament assemblies in the active lamella of fibroblasts: their morphogenesis and role in the formation of actin filament bundles","volume":"131","author":"Verkhovsky","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0640","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cm.970200304","article-title":"Dynamic morphology of metastatic mouse T-lymphoma cells invading through monolayers of 10T 1\/2 cells","volume":"20","author":"Verschueren","year":"1991","journal-title":"Cell Motil. Cytoskeleton"},{"key":"10.1016\/j.bbagen.2022.130113_bb0645","first-page":"4726","article-title":"Matrix metalloproteinase inhibitor BB-94 (Batimastat) inhibits human Colon tumor growth and spread in a patient-like Orthotopic model in nude mice","volume":"54","author":"Wang","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2022.130113_bb0650","doi-asserted-by":"crossref","first-page":"R891","DOI":"10.1016\/S0960-9822(00)00845-9","article-title":"Actin dynamics: assembly and disassembly of actin networks","volume":"10","author":"Wear","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0655","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1084\/jem.187.12.2091","article-title":"\u03921 Integrins are critically involved in neutrophil locomotion in extravascular tissue in vivo","volume":"187","author":"Werr","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbagen.2022.130113_bb0660","doi-asserted-by":"crossref","DOI":"10.1006\/excr.2000.5099","article-title":"Activation of beta1 integrins induces cell\u2013cell adhesion","volume":"263","author":"Whittard","year":"2001","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbagen.2022.130113_bb0665","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0945-053X(02)00037-9","article-title":"E-cadherin is a ligand for integrin \u03b12\u03b21","volume":"21","author":"Whittard","year":"2002","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0670","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1083\/jcb.200209006","article-title":"Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis","volume":"160","author":"Wolf","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0675","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1083\/jcb.147.3.619","article-title":"Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and Talin","volume":"147","author":"Carragher","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0680","first-page":"550","article-title":"Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber, AMA","volume":"66","author":"Wood","year":"1958","journal-title":"Arch. Pathol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0685","first-page":"4485","article-title":"Monoclonal antibody and synthetic peptide inhibitors of human tumor cell migration","volume":"50","author":"Yamada","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2022.130113_bb0690","first-page":"2004","article-title":"Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells","volume":"59","author":"Yoshioka","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2022.130113_bb0695","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s43094-021-00245-z","article-title":"Detection of 6-monoacetylemorphine in hair sample of heroin addicts using gas chromatography\u2013mass spectrometry and significance of rehabilitation program","volume":"7","author":"Ghauri","year":"2021","journal-title":"Fut. J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2022.130113_bb0700","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s43094-021-00184-9","article-title":"In vivo anti-inflammatory, antipyretic, analgesic activity and in vitro anti-proliferative activity of aqueous methanolic extract of Euphorbia granulata Forssk","volume":"7","author":"Ghauri","year":"2021","journal-title":"Fut. J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2022.130113_bb0705","first-page":"355","article-title":"In-vivo evaluation of analgesic, anti-inflammatory and anti-pyretic activity of aqueous methanolic extract of Jatropha gossypifolia, African","volume":"11","author":"Mohsin","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0710","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1158\/1078-0432.CCR-14-0012","article-title":"FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer","volume":"20","author":"Amiri-Kordestani","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2022.130113_bb0715","first-page":"1490","article-title":"Approval summary: Gemtuzumab ozogamicin in relapsed acute myeloid leukemia","volume":"7","author":"Bross","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2022.130113_bb0720","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1002\/anie.201307628","article-title":"Antibody-drug conjugates: an emerging concept in cancer therapy","volume":"53","author":"Chari","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2022.130113_bb0725","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1158\/1078-0432.CCR-17-3179","article-title":"Fda approval: Gemtuzumab ozogamicin for the treatment of adults with newly diagnosed cd33-positive acute myeloid leukemia","volume":"24","author":"Jen","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2022.130113_bb0730","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.drudis.2013.11.004","article-title":"Antibody\u2013drug conjugates: current status and future directions","volume":"19","author":"Perez","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbagen.2022.130113_bb0735","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/annonc\/mdr382","article-title":"Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: Back to the future?","volume":"23","author":"Ribeiro","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0740","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev-med-050311-201823","article-title":"Antibody-drug conjugates in cancer therapy","volume":"64","author":"Sievers","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbagen.2022.130113_bb0745","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrc2394","article-title":"Paul Ehrlich\u2019s magic bullet concept: 100 years of progress","volume":"8","author":"Strebhardt","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbagen.2022.130113_bb0750","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc3930","article-title":"Building better monoclonal antibody-based therapeutics","volume":"15","author":"Weiner","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbagen.2022.130113_bb0755","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbagen.2022.130113_bb0760","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbagen.2022.130113_bb0765","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor\u2013modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2022.130113_bb0770","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbagen.2022.130113_bb0775","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/278093","article-title":"Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cells","volume":"2012","author":"Maher","year":"2012","journal-title":"ISRN Oncol."},{"key":"10.1016\/j.bbagen.2022.130113_bb0780","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor\u2013modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2022.130113_bb0785","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.1882","article-title":"Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma","volume":"14","author":"Pule","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagen.2022.130113_bb0790","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.180.7.4901","article-title":"Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor","volume":"180","author":"Wilkie","year":"2008","journal-title":"J. Immunol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416522000319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416522000319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:12:55Z","timestamp":1759637575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416522000319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":158,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0304416522000319"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2022.130113","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic insights expatiating the biological role and regulatory implications of estrogen and HER2 in breast cancer metastasis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2022.130113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"130113"}}